ISPOR LATIN AMERICA CONSORTIUM PUBLISHES FIRST SCIENCE POLICY BRIEF

Published Jan 12, 2016

“BUDGET IMPACT ANALYSIS: NEW NORMS”

 Princeton, NJ—January 12, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its Latin America Consortium Publications Committee has published its first Science Policy Brief—Budget Impact Analysis: New Norms (El Análisis del Impacto Presupuestario: Nuevas Normas). This Science Policy Brief is based on the guidance recommendations from the ISPOR Task Force Report, “Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force,” published in Value in Health [2014 Jan-Feb;17(1):5-14]. The Latin America Consortium Science Policy Brief—Budget Impact Analysis: New Norms—is published in Spanish, Portuguese, and English. This new Science Policy Brief explores the issue of budget impact analyses (BIAs), which are an essential part of assessing affordability of health care interventions and are increasingly required by reimbursement authorities. This Brief, and the original Task Force Report, present updated guidance on methods for undertaking BIAs. For example, recommendations on new intervention BIA design should take into account: (1) relevant features of the health care system, (2) possible access restrictions, (3) the anticipated update of the new intervention, and (4) the use and effects of the current and new interventions. ISPOR Science Policy Briefs are designed to communicate consensus guidance recommendations of ISPOR Good Practices for Outcomes Research Reports in a format that is easily accessible and especially relevant for public and private stakeholders who have non-technical backgrounds. All of the Good Practices for Outcomes Research Reports may be found here. Additional information on the Latin America Consortium may be found here.

###

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×